The State Council has released an announcement regarding appointments and dismissals within the government. Among the changes, Li Li has been appointed to serve as the director of the National Medical Products Administration (NMPA), succeeding Jiao Hong who has left the position.
Li Li’s Extensive Experience in Healthcare and Administration
Li Li brings a wealth of experience to his new role at the NMPA. He has held various significant positions in the healthcare and administrative sectors. His career includes serving as the director of the Health Department, director of the Health and Family Planning Commission, and deputy governor of Jiangxi province. From March 2018 to September 2023, Li Li was a member of the leading Party group of the State Administration for Market Regulation. He also served as the secretary of the leading Party group and deputy director of the NMPA.
Implications of the Leadership Change at NMPA
The appointment of Li Li as the director of the NMPA marks a significant leadership transition for the agency. His extensive background in healthcare administration and regulatory affairs positions him well to lead the NMPA in its mission to oversee the medical products sector in China.-Fineline Info & Tech
